Effects of pancreatic kininogenase enteric-coated tablets on optic discand macular retinal hemodynamics in diabetic retinopathy
10.3969/j.issn.1005-1678.2017.01.044
- VernacularTitle:胰激肽原酶肠溶片对糖尿病视网膜病变患者视盘及黄斑部视网膜血流动力学的影响
- Author:
Feng CAI
;
Zhihong ZENG
;
Dongmei XU
;
Shaoqin LIU
;
Linli WU
- Keywords:
pancreatic kininogenase;
diabetic retinopathy;
optic disc;
macular;
retina;
hemodynamics
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(1):154-156
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the pancreatic kininogenase enteric-coated tablets in the treatment of diabetic retinopathy (DR) patients and its effect on the optic disc and macula retinal hemodynamics. Methods 86 cases (140 eyes) of DR patients were randomly divided into pancreatic kininogenase group and normal group with 43 cases in each group, two groups were treated with basic therapy, pancreatic kininogenase group were combined with pancreatic kininogenase treatment. The best corrected visual acuity and the clinical effect of optic disc and macula retinal hemodynamic changes were compared between two groups. Results After treatment, the best corrected visual acuity (BCVA) in pancreatic kininogenase group was greater than the normal group (P<0.05), the retinal neovascularization and fluorescein leakage area in pancreatic kininogenase group was less than the normal group (P<0.05). The disc vascular and macular retinal blood flow volume (VOL), blood flow velocity (FLW)values in pancreatic kininogenase group were larger than those of normal group, and the clinical curative effect of pancreatic kininogenase group was better than that of normal group (P<0.05). Conclusion Pancreatic kininogenase enteric-coated tablets in the treatment of DR patients can improve the optic disc and macular retinal hemodynamic parameters, improve visual acuity and reduce the retinal neovascularization and fluorescein leakage area, so as to improve the clinical treatment effect.
